Back to search

Article

Inversely proportional myelin growth due to altered <i>Pmp22</i> gene dosage identifies PI3K/Akt/mTOR signaling as a novel therapeutic target in HNPP

2021-11-08

Abstract excerpt

Duplication of the gene encoding the myelin protein PMP22 causes the hereditary neuropathy Charcot-Marie-Tooth disease 1A (CMT1A), characterized by hypomyelination of medium to large caliber peripheral axons. Conversely, haplo-insufficiency of PMP22 leads to focal myelin overgrowth in hereditary neuropathy with liability to pressure palsies (HNPP). However, the molecular mechanisms of myelin growth regulation by...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8020c179-3604-5488-98ac-648292305514
DOI
10.1101/2021.11.08.467756
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inversely proportional myelin growth due to altered <i>Pmp22</i> gene dosage identifies PI3K/Akt/mTOR signaling as a novel therapeutic target in HNPPDOI 10.1101/2021.11.08.467756
Select a neighboring publication to make it the new centre.